{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:13:38Z","timestamp":1790187218631,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T00:00:00Z","timestamp":1717891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.bbrep.2024.101755","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T14:13:56Z","timestamp":1718288036000},"page":"101755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Ovarian cancer ascites proteomic profile reflects metabolic changes during disease progression"],"prefix":"10.1016","volume":"39","author":[{"given":"Diana Lu\u00edsa","family":"Almeida-Nunes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Os\u00f3rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Henriques","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Bartosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Silvestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7430-6297","authenticated-orcid":false,"given":"Ricardo Jorge","family":"Dinis-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ricardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2024.101755_bib1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2147\/IJWH.S197604","article-title":"Ovarian cancer in the World: Epidemiology and Risk factors","volume":"11","author":"Momenimovahed","year":"2019","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.bbrep.2024.101755_bib2","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/cas.12987","article-title":"Ascites Modulates cancer cell behavior, contributing to tumor Heterogeneity in ovarian cancer","volume":"107","author":"Kim","year":"2016","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrep.2024.101755_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41416-020-0875-x","article-title":"The Untapped potential of ascites in ovarian cancer research and treatment","volume":"123","author":"Ford","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrep.2024.101755_bib4","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0140-6736(09)61338-6","article-title":"Ovarian cancer","volume":"374","author":"Hennessy","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.bbrep.2024.101755_bib5","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1074\/mcp.M114.041194","article-title":"Proteome\u2013metabolome profiling of ovarian cancer ascites reveals novel components involved in intercellular communication","volume":"13","author":"Shender","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bbrep.2024.101755_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ijgo.12617","article-title":"Pathology of cancers of the female genital tract including molecular pathology","volume":"143","author":"Prat","year":"2018","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.bbrep.2024.101755_bib7","first-page":"171","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"126","author":"Prat","year":"2015","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.bbrep.2024.101755_bib8","series-title":"Ovarian Cancer","first-page":"27","article-title":"Chemoresistance in ovarian cancer: the role of malignant ascites","author":"Nunes","year":"2022"},{"key":"10.1016\/j.bbrep.2024.101755_bib9","series-title":"Ovarian Cancer","first-page":"43","article-title":"Ovarian cancer ascites as a liquid tumor microenvironment","author":"Nunes","year":"2022"},{"key":"10.1016\/j.bbrep.2024.101755_bib10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrc3432","article-title":"Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research","volume":"13","author":"Kipps","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrep.2024.101755_bib11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1021\/pr0703223","article-title":"A Proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers","volume":"7","author":"Gortzak-Uzan","year":"2008","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbrep.2024.101755_bib12","first-page":"1","article-title":"Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research","volume":"3 SEP","author":"Ahmed","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrep.2024.101755_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10147-012-0396-6","article-title":"Malignant ascites: pathophysiology and treatment","volume":"18","author":"Cavazzoni","year":"2013","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.bbrep.2024.101755_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41416-020-0875-x","article-title":"The untapped potential of ascites in ovarian cancer research and treatment","volume":"123","author":"Ford","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrep.2024.101755_bib15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3390\/jcm10030407","article-title":"Proteomics analysis of gastric cancer patients with diabetes mellitus","volume":"10","author":"Os\u00f3rio","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbrep.2024.101755_bib16","article-title":"Reactive protein and risk of ovarian cancer","volume":"96","author":"Li","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.bbrep.2024.101755_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77167-y","article-title":"Clinical usefulness of high levels of C-reactive protein for diagnosing epithelial ovarian cancer","volume":"10","author":"Yang","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrep.2024.101755_bib18","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1080\/01635581.2020.1798479","article-title":"Significance of pretreatment C-reactive protein, albumin, and C-reactive protein to albumin ratio in predicting poor prognosis in epithelial ovarian cancer patients","volume":"73","author":"Komura","year":"2021","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.bbrep.2024.101755_bib19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12885-017-3220-x","article-title":"The prognostic value of the preoperative C-reactive protein\/albumin ratio in ovarian cancer","volume":"17","author":"Liu","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrep.2024.101755_bib20","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/01.AOG.0000257126.68803.03","article-title":"C-reactive protein concentrations and subsequent ovarian cancer risk","volume":"109","author":"McSorley","year":"2007","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.bbrep.2024.101755_bib21","article-title":"Association between C-reactive protein level and subsequent risk of ovarian cancer","volume":"99","author":"Wang","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.bbrep.2024.101755_bib22","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s10552-009-9330-2","article-title":"C-reactive protein and ovarian cancer: a prospective study nested in three cohorts (Sweden, USA, Italy)","volume":"20","author":"Lundin","year":"2009","journal-title":"Cancer Causes & Control"},{"key":"10.1016\/j.bbrep.2024.101755_bib23","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.1158\/0008-5472.CAN-19-1554","article-title":"High levels of C-reactive protein are associated with an increased risk of ovarian cancer: results from the ovarian cancer cohort consortium","volume":"79","author":"Peres","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrep.2024.101755_bib24","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1158\/1078-0432.CCR-07-1044","article-title":"Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer","volume":"14","author":"Hefler","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrep.2024.101755_bib25","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/annonc\/mdq694","article-title":"Changes in pre-diagnostic serum C-reactive protein concentrations and ovarian cancer risk: a longitudinal study","volume":"22","author":"Toriola","year":"2011","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbrep.2024.101755_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejogrb.2009.06.010","article-title":"Serum C-reactive protein in the differential diagnosis of ovarian masses","volume":"147","author":"Hefler-Frischmuth","year":"2009","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.bbrep.2024.101755_bib27","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/aje\/kwt098","article-title":"A prospective study of circulating C-reactive protein, interleukin-6, and tumor necrosis factor \u03b1 receptor 2 levels and risk of ovarian cancer","volume":"178","author":"Poole","year":"2013","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.bbrep.2024.101755_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0301-2115(98)00227-9","article-title":"Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer","volume":"82","author":"Kodama","year":"1999","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.bbrep.2024.101755_bib29","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.3892\/etm.2015.2350","article-title":"Prognostic evaluation of preoperative serum C-reactive protein concentration in patients with epithelial ovarian cancer","volume":"9","author":"Lu","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bbrep.2024.101755_bib30","doi-asserted-by":"crossref","DOI":"10.1177\/03000605231218557","article-title":"Diagnostic roles of neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio, C-reactive protein, and cancer antigen 125 for ovarian cancer","volume":"51","author":"Ye","year":"2023","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.bbrep.2024.101755_bib31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12957-023-03290-5","article-title":"Prognostic and clinicopathological significance of C-reactive protein in patients with ovarian cancer: a meta-analysis","volume":"22","author":"Zhang","year":"2024","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.bbrep.2024.101755_bib32","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.2147\/CMAR.S359968","article-title":"Pre-treatment CRP-albumin-lymphocyte index (CALLY index) as a prognostic biomarker of survival in patients with epithelial ovarian cancer","volume":"14","author":"Wang","year":"2022","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.bbrep.2024.101755_bib33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tice.2018.05.014","article-title":"Eukaryotic elongation factors 2 promotes tumor cell proliferation and correlates with poor prognosis in ovarian cancer","volume":"53","author":"Shi","year":"2018","journal-title":"Tissue Cell"},{"key":"10.1016\/j.bbrep.2024.101755_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.109938","article-title":"Targeting eukaryotic elongation factor-2 kinase suppresses the growth and peritoneal metastasis of ovarian cancer","volume":"81","author":"Erdogan","year":"2021","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbrep.2024.101755_bib35","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1158\/1078-0432.CCR-03-0103","article-title":"Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer","volume":"10","author":"Davies","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrep.2024.101755_bib36","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-2006-948556","article-title":"Extracellular matrix of ovarian tumors","volume":"24","author":"Ricciardelli","year":"2006","journal-title":"Semin. Reprod. Med."},{"key":"10.1016\/j.bbrep.2024.101755_bib37","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.nano.2019.01.017","article-title":"HBO1 directs histone H4 specific acetylation, potentiating mechano-transduction pathways and membrane elasticity in ovarian cancer cells","volume":"17","author":"Quintela","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bbrep.2024.101755_bib38","first-page":"121","article-title":"Apoptin gene transfer via modified wheat histone H4 facilitates apoptosis of human ovarian cancer cells","volume":"26","author":"Wang","year":"2011","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.bbrep.2024.101755_bib39","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1021\/acs.jproteome.7b00405","article-title":"Targeted proteomic analyses of histone H4 acetylation changes associated with homologous-recombination-deficient high-grade serous ovarian carcinomas","volume":"16","author":"Thomas","year":"2017","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbrep.2024.101755_bib40","doi-asserted-by":"crossref","DOI":"10.3892\/or.2011.1483","article-title":"Correlations among ERCC1, XPB, UBE2I, EGF, TAL2 and ILF3 revealed by gene signatures of histological subtypes of patients with epithelial ovarian cancer","author":"Yu","year":"2011","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbrep.2024.101755_bib41","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1002\/ijc.29197","article-title":"Identification of novel candidate biomarkers of epithelial ovarian cancer by profiling the secretomes of three-dimensional genetic models of ovarian carcinogenesis","volume":"137","author":"Lawrenson","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrep.2024.101755_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2019.02.019","article-title":"Proteases and their inhibitors as prognostic factors for high-grade serous ovarian cancer","volume":"215","author":"Trudel","year":"2019","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.bbrep.2024.101755_bib43","doi-asserted-by":"crossref","first-page":"7355","DOI":"10.2147\/CMAR.S303707","article-title":"Obesity promotes tumor immune evasion in ovarian cancer through increased production of myeloid-derived suppressor cells via IL-6","volume":"13","author":"Yang","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.bbrep.2024.101755_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb5817","article-title":"Reactivation of dormant tumor cells by modified lipids derived from stress-activated neutrophils","volume":"12","author":"Perego","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbrep.2024.101755_bib45","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3390\/cancers12020505","article-title":"Neutrophil extracellular trap formation correlates with favorable overall survival in high grade ovarian cancer","volume":"12","author":"Muqaku","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bbrep.2024.101755_bib46","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.1021\/pr100478u","article-title":"Proteomic identification of paclitaxel-resistance associated HnRNP A2 and GDI 2 proteins in human ovarian cancer cells","volume":"9","author":"Lee","year":"2010","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbrep.2024.101755_bib47","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4149\/neo_2018_101","article-title":"Proteomic alterations of fibroblasts induced by ovarian cancer cells reveal potential cancer targets","volume":"65","author":"Zhang","year":"2018","journal-title":"Neoplasma"},{"key":"10.1016\/j.bbrep.2024.101755_bib48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13048-020-00669-w","article-title":"Serum amyloid a, a potential biomarker both in serum and tissue, correlates with ovarian cancer progression","volume":"13","author":"Li","year":"2020","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.bbrep.2024.101755_bib49","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4110\/in.2017.17.2.121","article-title":"Augmented serum amyloid A1\/2 mediated by TNF-induced NF-\u03bab in human serous ovarian epithelial tumors","volume":"17","author":"Choi","year":"2017","journal-title":"Immune Netw"},{"key":"10.1016\/j.bbrep.2024.101755_bib50","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1369\/jhc.2010.956821","article-title":"Expression of serum amyloid A in human ovarian epithelial tumors: implication for a role in ovarian tumorigenesis","volume":"58","author":"Urieli-Shoval","year":"2010","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.bbrep.2024.101755_bib51","doi-asserted-by":"crossref","first-page":"16391","DOI":"10.1007\/s00432-023-05296-8","article-title":"Identification of SAA1 as a novel metastasis marker in ovarian cancer and development of a graphene-based detection platform for early assessment","volume":"149","author":"Zhao","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bbrep.2024.101755_bib52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10555-013-9456-2","article-title":"Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition","volume":"33","author":"Thibault","year":"2014","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbrep.2024.101755_bib53","doi-asserted-by":"crossref","first-page":"R55","DOI":"10.1530\/JME-15-0254","article-title":"What's new in estrogen receptor action in the female reproductive tract","volume":"56","author":"Hewitt","year":"2016","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.bbrep.2024.101755_bib54","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40164-018-0116-7","article-title":"Mechanisms for estrogen receptor expression in human cancer","volume":"7","author":"Hua","year":"2018","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.bbrep.2024.101755_bib55","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1152\/physrev.00024.2016","article-title":"Membrane and nuclear estrogen receptor alpha actions: from tissue specificity to medical implications","volume":"97","author":"Arnal","year":"2017","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbrep.2024.101755_bib56","doi-asserted-by":"crossref","unstructured":"He, J.; Siu, M.K.Y.; Ngan, H.Y.S.; Chan, K.K.L. Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets., doi:10.3389\/fonc.2021.738177.","DOI":"10.3389\/fonc.2021.738177"},{"key":"10.1016\/j.bbrep.2024.101755_bib57","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fonc.2017.00024","article-title":"The unique molecular and cellular microenvironment of ovarian cancer","volume":"7","author":"Worzfeld","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrep.2024.101755_bib58","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.bbrep.2024.101755_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12420","article-title":"Proteomic analysis of ascitic extracellular vesicles describes tumour microenvironment and predicts patient survival in ovarian cancer","volume":"13","author":"Vyhl\u00eddalov\u00e1 Kotrbov\u00e1","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.bbrep.2024.101755_bib60","article-title":"Apolipoprotein C\u2010II induces EMT to promote gastric cancer peritoneal metastasis via PI3K\/AKT\/MTOR pathway","volume":"11","author":"Wang","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbrep.2024.101755_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.592413","article-title":"Ubiquitin-like modifier activating enzyme 1 as a novel diagnostic and prognostic indicator that correlates with ferroptosis and the malignant phenotypes of liver cancer cells","volume":"10","author":"Shan","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrep.2024.101755_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2018.01345","article-title":"TMEM proteins in cancer: a review","volume":"9","author":"Schmit","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrep.2024.101755_bib63","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.acthis.2011.12.006","article-title":"Abnormal accumulation of human transmembrane (TMEM)-176A and 176B proteins is associated with cancer pathology","volume":"114","author":"Cuajungco","year":"2012","journal-title":"Acta Histochem."},{"key":"10.1016\/j.bbrep.2024.101755_bib64","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1155\/2013\/427890","article-title":"TMEM25 is a candidate biomarker methylated and down-regulated in colorectal cancer","volume":"34","author":"Hra\u0161ovec","year":"2013","journal-title":"Dis. Markers"},{"key":"10.1016\/j.bbrep.2024.101755_bib65","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cancergencyto.2007.04.007","article-title":"The interferon-alpha responsive gene TMEM7 suppresses cell proliferation and is downregulated in human hepatocellular carcinoma","volume":"177","author":"Zhou","year":"2007","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.bbrep.2024.101755_bib66","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1007\/s13277-015-4014-x","article-title":"Overexpression and biological function of TMEM48 in non-small cell lung carcinoma","volume":"37","author":"Qiao","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.bbrep.2024.101755_bib67","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1186\/s12885-015-1530-4","article-title":"Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of CcRCC tumors","volume":"15","author":"Wrzesi\u0144ski","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrep.2024.101755_bib68","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000239795","article-title":"REPS2 and meis 1: favourable prognostic and predictive biomarkers for breast cancer","volume":"30","author":"Doolan","year":"2009","journal-title":"Tumour Biol"},{"key":"10.1016\/j.bbrep.2024.101755_bib69","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1158\/0008-5472.CAN-14-3828","article-title":"Cytosolic TMEM88 promotes invasion and metastasis in lung cancer cells by binding DVLS","volume":"75","author":"Zhang","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrep.2024.101755_bib70","first-page":"1","article-title":"Knockdown of TMEM132A restrains the malignant phenotype of gastric cancer cells via inhibiting wnt signaling","author":"Gao","year":"2022","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.bbrep.2024.101755_bib71","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.3390\/cancers13164178","article-title":"Ovarian cancer and cancer stem cells\u2014cellular and molecular characteristics, signaling pathways, and usefulness as a diagnostic tool in medicine and Oncology","volume":"13","author":"Nowicki","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbrep.2024.101755_bib72","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.gde.2007.12.007","article-title":"Immune surveillance: a balance between protumor and antitumor immunity","volume":"18","author":"Ostrand-Rosenberg","year":"2008","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.bbrep.2024.101755_bib73","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cyto.2015.05.026","article-title":"Targeting of IL-4 and IL-13 receptors for cancer therapy","volume":"75","author":"Suzuki","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.bbrep.2024.101755_bib74","article-title":"Immune tumor microenvironment in ovarian cancer ascites","volume":"2022","author":"Lu\u00edsa Almeida-Nunes","year":"2022","journal-title":"Ovarian Cancer Ascites. Int. J. Mol. Sci"},{"key":"10.1016\/j.bbrep.2024.101755_bib75","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.4049\/jimmunol.1102095","article-title":"A novel combination immunotherapy for cancer by IL-13r\u03b12-targeted DNA vaccine and immunotoxin in murine tumor models","volume":"187","author":"Nakashima","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrep.2024.101755_bib76","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.4161\/cc.9.24.14322","article-title":"Alternative activation of tumor-associated macrophages by IL-4: priming for protumoral functions","volume":"9","author":"Wang","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbrep.2024.101755_bib77","first-page":"551","article-title":"Structure of and signal transduction through interleukin-4 and interleukin-13 receptors","volume":"1","author":"Murata","year":"1998","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bbrep.2024.101755_bib78","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/sj.cdd.4402305","article-title":"Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4","volume":"15","author":"Todaro","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbrep.2024.101755_bib79","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/ijc.26366","article-title":"IL-13 regulates cancer invasion and metastasis through IL-13r\u03b12 via ERK\/AP-1 pathway in mouse model of human ovarian cancer","volume":"131","author":"Fujisawa","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrep.2024.101755_bib80","doi-asserted-by":"crossref","first-page":"6601","DOI":"10.7150\/thno.37549","article-title":"Dual-platform affinity proteomics identifies links between the recurrence of ovarian carcinoma and proteins released into the tumor microenvironment","volume":"9","author":"Finkernagel","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.bbrep.2024.101755_bib81","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.1158\/0008-5472.CAN-12-3544","article-title":"Cytokine stimulation of epithelial cancer cells: the similar and divergent functions of IL-4 and IL-13","volume":"72","author":"Hallett","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrep.2024.101755_bib82","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nri.2015.10","article-title":"The multifaceted role of CD4(+) T cells in CD8(+) T cell memory","volume":"16","author":"Laidlaw","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbrep.2024.101755_bib83","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1158\/2326-6066.CIR-16-0060","article-title":"Response to programmed cell death-1 blockade in a murine melanoma syngeneic model requires costimulation, CD4, and CD8 T cells","volume":"4","author":"Homet Moreno","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbrep.2024.101755_bib84","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cell.2016.12.022","article-title":"Systemic immunity is required for effective cancer immunotherapy","volume":"168","author":"Spitzer","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bbrep.2024.101755_bib85","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1158\/0008-5472.CAN-15-3130","article-title":"CD27 agonism plus PD-1 blockade recapitulates CD4+ T-cell help in therapeutic anticancer vaccination","volume":"76","author":"Ahrends","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrep.2024.101755_bib86","article-title":"Expression of the MHC class II in triple-negative breast cancer is associated with tumor-infiltrating lymphocytes and interferon signaling","volume":"12","author":"Park","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrep.2024.101755_bib87","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10582","article-title":"Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1\/PD-L1 therapy","volume":"7","author":"Johnson","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrep.2024.101755_bib88","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1158\/2326-6066.CIR-15-0243","article-title":"Expression of the MHC class II pathway in triple-negative breast cancer tumor cells is associated with a good prognosis and infiltrating lymphocytes","volume":"4","author":"Forero","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbrep.2024.101755_bib89","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1200\/JCO.2017.77.3994","article-title":"Major histocompatibility complex class II and programmed death ligand 1 expression predict outcome after programmed death 1 blockade in classic hodgkin lymphoma","volume":"36","author":"Roemer","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbrep.2024.101755_bib90","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar3342","article-title":"MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma","volume":"10","author":"Rodig","year":"2018","journal-title":"Sci. Transl. Med."}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580824001195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580824001195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T00:40:28Z","timestamp":1728088828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580824001195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":90,"alternative-id":["S2405580824001195"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2024.101755","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovarian cancer ascites proteomic profile reflects metabolic changes during disease progression","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2024.101755","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101755"}}